ROIS: The CDMO making waves in the US market Learn more →

Sterile manufacturing

ROIS provides aseptic manufacturing across 14 filling lines, with a choice of flexible, cost-efficient RABS or the latest isolator technology, all Annex 1-compliant.

Built for scale

Supporting end-to-end late-phase and commercial manufacturing for complex injectable drug products including prefilled syringes, cartridges and vials, with specialized expertise in biologics, segregated cytotoxic lyophilization and ADC fill-finish, plus downstream services including packaging, device assembly and quality release.

700M+ PFS/year

Annual sterile PFS fill

100M+ vials/year

Annual sterile vial fill

14 aseptic lines

Competitive capability

16 packaging lines

End-to-end capability

FAQs

ROIS provides sterile fill-finish across prefilled syringes, cartridges and vials, with flexible manufacturing capabilities supporting complex injectable products from late-stage clinical programs through commercial supply. Its global capacity exceeds 800 million units annually across these formats.

The ROIS standard

  • Partnership

    Collaborating with clients as strategic partners, with flexible, adaptable models

  • Impact

    Strengthening the supply of medicine to patients through reliable manufacturing

  • Integrity

    Steadfast standards in every submission, batch and conversation

  • Responsibility

    Operating in a way that demonstrates responsibility to people, communities and the planet

Personalized partnerships. Global reach.

Connect with the ROIS team to explore how this capability can support your next program.